20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
It seems that it is impossible to talk to any fund today without learning that a SPAC is planned or ...
Read More >
Liability insurers charge premiums in exchange for an agreement to cover certain claims against thei...
Read More >
Changes in how businesses operate, restrictions on property use and reduced revenues brought on by m...
Read More >
On June 25, 2020, the Fifth Appellate District decided Honchariw v. County of Stanislaus, holding th...
Read More >
During the 2020 session, the Florida Legislature enacted a number of provisions intended to ease the...
Read More >
Being a 401(k) plan sponsor is an incredible responsibility and the problem is that you may not even...
Read More >